MedPath

Intraosseous Morphine Administration During Anterior Cruciate Ligament Reconstruction

Phase 4
Recruiting
Conditions
Anterior Cruciate Ligament Tear
Anterior Cruciate Ligament Injuries
Anterior Cruciate Ligament Rupture
Registration Number
NCT06511232
Lead Sponsor
The Methodist Hospital Research Institute
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Recruiting
Sex
All
Target Recruitment
84
Inclusion Criteria

Inclusion Criteria:<br><br> - Patients of the IRB approved surgeon(s) undergoing ACL reconstruction with<br> bone-to-bone (BTB) autograft<br><br> - Patients aged between 18-40 years old at the time of surgery<br><br>Exclusion Criteria:<br><br> - Patients undergoing ACL reconstruction with any other type of autograft or allograft<br> other than BTB<br><br> - Patients younger than 18 years old or older than 40 years old<br><br> - Patients undergoing meniscal root repair or any other repair that changes their<br> weight-bearing status<br><br> - Patients with a history of substance abuse<br><br> - Vulnerable populations<br><br> - Patients on chronic pain medication within the last 6 months<br><br> - BMI >/= 35<br><br> - Allergy to morphine<br><br> - Unwilling to participate<br><br> - Any additional reason the PI deems reasonable

Exclusion Criteria

Not provided

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Patient Pain Levels in the Post-Operative Period as assessed by a patient-reported post operative symptom journal.;Changes in Post-Operative Opioid Use;Patient Pain Levels in the Post-Operative Period as assessed by the Lysholm Knee Survey
Secondary Outcome Measures
NameTimeMethod
Patient Range of Motion in the Post-Operative Period as assessed by the KOOS, JR. Knee Survey;Patient Activity Level in the Post-Operative Period as assessed by the Tegner scale.;Patient Range of Motion in the Post-Operative Period as assessed by the Lysholm Knee Survey
© Copyright 2025. All Rights Reserved by MedPath